A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
16h
inews.co.uk on MSNThe future of weight loss drugs: gummies, tablets and melt-in-the-mouth stripsThe race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...
A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...
OB-GYNs explain how they're using semaglutide and tirzepatide to treat symptoms of PCOS. The meds help treat weight gain, ...
15hon MSN
Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...
A new study suggests that restoring the pleasure of eating – not suppressing it – may help people eat more intentionally and ...
9h
Health on MSNFDA Says Ozempic Is No Longer in Shortage—Does That Mean the End of Cheaper Copycat Versions?Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...
Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting its sales.
A running belt should be comfortable enough that you can forget it’s there. “A lot of it is finding the positioning and ...
Novo Nordisk has licensed an oral obesity drug that works via an uncommon mechanism and may help patients maintain their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results